DE60021360D1 - Vegf angiogenische wachstumsfaktoren zur behandlung von peripheren neuropathie - Google Patents

Vegf angiogenische wachstumsfaktoren zur behandlung von peripheren neuropathie

Info

Publication number
DE60021360D1
DE60021360D1 DE60021360T DE60021360T DE60021360D1 DE 60021360 D1 DE60021360 D1 DE 60021360D1 DE 60021360 T DE60021360 T DE 60021360T DE 60021360 T DE60021360 T DE 60021360T DE 60021360 D1 DE60021360 D1 DE 60021360D1
Authority
DE
Germany
Prior art keywords
treatment
growth factors
peripheral neuropathy
angiogenic growth
vegf angiogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60021360T
Other languages
English (en)
Other versions
DE60021360T2 (de
Inventor
M Isner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Caritas St Elizabeth Medical Center of Boston
St Elizabeths Medical Center of Boston Inc
Original Assignee
Caritas St Elizabeth Medical Center of Boston
St Elizabeths Medical Center of Boston Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caritas St Elizabeth Medical Center of Boston, St Elizabeths Medical Center of Boston Inc filed Critical Caritas St Elizabeth Medical Center of Boston
Publication of DE60021360D1 publication Critical patent/DE60021360D1/de
Application granted granted Critical
Publication of DE60021360T2 publication Critical patent/DE60021360T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60021360T 1999-04-15 2000-04-11 Vegf angiogenische wachstumsfaktoren zur behandlung von peripherer neuropathie Expired - Fee Related DE60021360T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12976899P 1999-04-15 1999-04-15
US129768P 1999-04-15
PCT/US2000/009765 WO2000062798A2 (en) 1999-04-15 2000-04-11 Angiogenic growth factors for treatment of peripheral neuropathy

Publications (2)

Publication Number Publication Date
DE60021360D1 true DE60021360D1 (de) 2005-08-25
DE60021360T2 DE60021360T2 (de) 2006-05-24

Family

ID=22441512

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60021360T Expired - Fee Related DE60021360T2 (de) 1999-04-15 2000-04-11 Vegf angiogenische wachstumsfaktoren zur behandlung von peripherer neuropathie

Country Status (6)

Country Link
EP (1) EP1169052B1 (de)
AU (1) AU782819B2 (de)
CA (1) CA2365434A1 (de)
DE (1) DE60021360T2 (de)
HK (1) HK1042250A1 (de)
WO (1) WO2000062798A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223724B1 (en) 1999-02-08 2007-05-29 Human Genome Sciences, Inc. Use of vascular endothelial growth factor to treat photoreceptor cells
CA2381780C (en) 1999-08-13 2015-03-10 Chiron Corporation Dose of an angiogenic factor and method of administering to improve myocardial blood flow
ATE409494T1 (de) * 1999-10-29 2008-10-15 Anges Mg Inc Gentherapie für diabetische ischämie
EP2277528B1 (de) * 2000-04-12 2014-11-12 Vib Vzw Verwendung von VEGF und Homologen zur Behandlung von neurologischen Störungen
CN1211126C (zh) 2000-08-04 2005-07-20 人体基因组科学有限公司 血管内皮生长因子2
CA2444632A1 (en) 2001-04-13 2002-10-24 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
AU2003281878A1 (en) * 2002-11-12 2004-06-03 Xenon Genetics Inc. Hsan ii related gene and expression products and uses thereof
EP1663293A2 (de) * 2003-09-23 2006-06-07 Ludwig Institute For Cancer Research Vege-cor vege-d-materialien und verfahren zur stimulation der neuralen stammzellen
WO2005097166A1 (ja) * 2004-04-09 2005-10-20 Kaken Pharmaceutical Co., Ltd. ゼラチンゲルを担体とする糖尿病性神経障害治療剤
WO2005117946A1 (en) 2004-05-27 2005-12-15 Vib Vzw Treatment of amyotrophic lateral sclerosis
CU23526B6 (es) * 2006-10-03 2010-05-19 Ct Ingenieria Genetica Biotech Método para la restauración morfofuncional de nervios periféricos en la neuropatía diabética
KR100812274B1 (ko) * 2006-10-30 2008-03-13 한양대학교 산학협력단 Ｇ-ｃｓｆ를 유효성분으로 하는 당뇨성 말초신경병 예방 및치료제
WO2011022045A2 (en) * 2009-08-17 2011-02-24 Singh Ashok K Apparatus and process for generating and harvesting adult stem cells and fluid associated with it from skin and omentum for medical, cosmetic, and veterinary use
US9051351B2 (en) * 2011-04-02 2015-06-09 Washington State University Hepatocyte growth factor mimics as therapeutic agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604202A (en) * 1990-11-13 1997-02-18 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Use of NGF growth factors to treat drug-induced neuropathy
AU663067B2 (en) * 1990-12-18 1995-09-28 Amgen, Inc. Analogs of acidic fibroblast growth factor having enhanced stability and biological activity
US5420112A (en) * 1992-06-12 1995-05-30 Lewis; Michael E. Prevention and treatment of peripheral neuropathy
AU1121997A (en) * 1995-11-29 1997-06-19 Amgen, Inc. Method for treating sensory neuropathy using glial cell line-derived neurotrophic factor (gdnf) protein product
WO1999036103A1 (en) * 1998-01-16 1999-07-22 Mcgill University Prevention and treatment of neuropathy by hepatocyte growth factor

Also Published As

Publication number Publication date
CA2365434A1 (en) 2000-10-26
HK1042250A1 (en) 2002-08-09
EP1169052A2 (de) 2002-01-09
WO2000062798A3 (en) 2001-01-04
EP1169052B1 (de) 2005-07-20
AU4342700A (en) 2000-11-02
WO2000062798A2 (en) 2000-10-26
AU782819B2 (en) 2005-09-01
DE60021360T2 (de) 2006-05-24

Similar Documents

Publication Publication Date Title
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE305306T1 (de) Reboxetin zur behandlung von peripheren neuropathien
DE60045386D1 (de) Gerät zur thermischen behandlung von bandscheiben
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
ATE400283T1 (de) Reovirus zur behandlung von zellulären proliferativen erkrankungen
DE69903543D1 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
DE60113496D1 (de) Verwendung von Glycyrrhizin zur Behandlung von Mastitis.
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60011570D1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60021360D1 (de) Vegf angiogenische wachstumsfaktoren zur behandlung von peripheren neuropathie
DE60012138D1 (de) Gerät zur behandlung von fibrillation
DE60014928D1 (de) Retinoide zur behandlung von emphysem
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE60001255T2 (de) Zusammensetzung zur Behandlung von Polyesterfaser
DE60018200D1 (de) Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
ATE253578T1 (de) Oxazinochinolone zur behandlung von viralen infektionen
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
ATE285764T1 (de) Rivastigmine zur behandlung von augenerkrankungen
DE60005685D1 (de) Oxazinocarbazole zur behandlung von cns-erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee